February 12-15, 2023 | Eldorado Hotel & Spa, Santa Fe, NM, United States
Scientific Organizers:
Sean M. Wu, Wolfram H. Zimmermann and Christine E. Seidman
February 12-15, 2023 | Eldorado Hotel & Spa, Santa Fe, NM, United States
Scientific Organizers:
Sean M. Wu, Wolfram H. Zimmermann and Christine E. Seidman
Important Deadlines
Meeting Summary
Significant advances in recent years in mechanistic understanding of cardiac development, function, and degeneration have stimulated interest in identifying novel therapeutic agents that may help treat children and adult patients with cardiovascular diseases. However, therapies developed in cell and animal models rarely translate well to human patients. The goals of this conference are to advance our understanding of heart formation and homeostatic function and how derangement in these processes lead to diseases and organ dysfunction. Because human cardiovascular tissue is difficult to obtain for experimental perturbation this conference will address the use of a spectrum of cells and engineered tissue models as well as small and large animal models of disease. We anticipate that bringing together scientists with diverse research backgrounds who employ different tools and technologies to address mechanisms of cardiomyocyte and vascular dysfunction will result in new approaches to uncovering cardiovascular biology. Presentations will showcase innovative, molecularly targeted, strategies to treat both rare and common cardiovascular diseases.
SPECIAL RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
KEYSTONE SYMPOSIA THANKS OUR MEETING EXHIBITOR(S):
KEYSTONE SYMPOSIA THANKS THESE DONOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
THESE COMPANIES HAVE GENEROUSLY AGREED TO COVER THE EXPENSES OF THEIR EMPLOYEES WHO ARE SPEAKING AT THIS MEETING:
GRANT RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS
Subscribe for Updates